These data indicated that DUSP family proteins, as feedback loops of lorlatinib, play important roles in the establishment of adaptive resistance via JNK/c-Jun activation in ALK-rearranged NSCLC, leading to the activation of HB-EGF/EGFR signaling. Here, ALK is linked to non-small cell lung carcinoma.